GE HealthCare shareholders back board, governance and compensation

GE Healthcare Technologies Inc ( (GEHC) ) has issued an update.

At its annual meeting of stockholders held on May 7, 2026, GE HealthCare Technologies Inc. shareholders elected eight directors to one-year terms ending at the 2027 annual meeting and gave advisory approval to the company’s executive compensation program. Stockholders also ratified Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026, while the board named Rodney F. Hochman independent lead director and appointed Anne T. Madden as chair of the Nominating and Governance Committee, signaling continuity in governance and oversight structures.

These voting outcomes underscore broad investor support for the company’s current leadership, governance framework and compensation practices, which may help GE HealthCare maintain stability as it executes its strategy in the competitive medical technology market. The designation of an independent lead director and refreshed committee leadership could strengthen board independence and governance focus, factors closely watched by institutional investors and other stakeholders.

The most recent analyst rating on (GEHC) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.

Spark’s Take on GEHC Stock

According to Spark, TipRanks’ AI Analyst, GEHC is a Neutral.

The score is held back primarily by weak technicals and recent TTM softness in profitability and free cash flow alongside moderate leverage. Offsetting factors include a reasonable valuation and an earnings outlook that maintains revenue growth guidance and demand visibility (record backlog), though near-term margins and EPS face notable cost and tariff headwinds.

To see Spark’s full report on GEHC stock, click here.

More about GE Healthcare Technologies Inc

GE HealthCare Technologies Inc. operates in the medical technology and healthcare solutions industry, providing imaging, diagnostics and patient monitoring equipment and related services to hospitals and healthcare providers worldwide. The company focuses on enabling precision care and improving clinical workflows through advanced healthcare technologies and digital tools.

Average Trading Volume: 4,354,525

Technical Sentiment Signal: Sell

Current Market Cap: $28.87B

For an in-depth examination of GEHC stock, go to TipRanks’ Overview page.